Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NAMPT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CASP7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSEN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BLZF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EGF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC7A11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FGA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ZCCHC10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CEP350 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RICTOR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRC19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FEM1C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUFIP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNX3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EXOC3-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ELOVL7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on